Immunotherapy Followed by Targeted Therapy Shows OS Benefit in BRAF-Mutated Melanoma
Pharmacy Times,
Melanoma treatment has progressed dramatically in the past decade. For patients with BRAF V600–mutated disease, immunotherapy…
Melanoma treatment has progressed dramatically in the past decade. For patients with BRAF V600–mutated disease, immunotherapy…
Medical Journeys > Melanoma More effective therapy, more treatment choices, more considerations for clinical decisions by…
FoundationOne CDx is a next-generation sequencing based in vitro diagnostic device for detection, insertion and deletion…
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Foundation Medicine, Inc. today announced that it has received approval from the U.S.